These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7512276

  • 1. Dose-intensive chemotherapy in extensive-stage small cell lung cancer.
    Fukuoka M, Masuda N, Takada M, Kodama N, Kawahara M, Furuse K.
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):43-7. PubMed ID: 7512276
    [No Abstract] [Full Text] [Related]

  • 2. Dose-intensive chemotherapy with cisplatin, vincristine, doxorubicin and etoposide against lung cancer: a pilot study.
    Yanagawa H, Bando H, Takishita Y.
    Anticancer Res; 1995 Feb; 15(2):613-6. PubMed ID: 7539241
    [Abstract] [Full Text] [Related]

  • 3. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K, Pan Z, Wood ME, Murphy J, Bunn PA.
    Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
    [Abstract] [Full Text] [Related]

  • 4. Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group.
    Furuse K, Fukuoka M, Nishiwaki Y, Kurita Y, Watanabe K, Noda K, Ariyoshi Y, Tamura T, Saijo N.
    J Clin Oncol; 1998 Jun; 16(6):2126-32. PubMed ID: 9626212
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The addition of cisplatin to cyclophosphamide-doxorubicin-etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma: A randomized study of 457 patients. "Petites Cellules" Group.
    Urban T, Chastang C, Lebas FX, Duhamel JP, Adam G, Darse J, Bréchot JM, Lebeau B.
    Cancer; 1999 Dec 01; 86(11):2238-45. PubMed ID: 10590363
    [Abstract] [Full Text] [Related]

  • 7. [Small cell bronchial cancer. Comparison of results of weekly polychemotherapy using multiple drugs with standard chemotherapy. European Lung Cancer Working Party].
    Sculier JP, Paesmans M, Bureau G, Dabouis G, Libert P, Vandermoten G, Van Cutsem O, Berchier MC, Ries F, Michel J.
    Rev Mal Respir; 1994 Dec 01; 11(3):257-61. PubMed ID: 8041988
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Brugger W, Frommhold H, Pressler K, Mertelsmann R, Kanz L.
    Semin Oncol; 1995 Feb 01; 22(1 Suppl 2):3-8. PubMed ID: 7531368
    [Abstract] [Full Text] [Related]

  • 10. Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
    Yuen AR, Fuks JZ, Ettinger DS, Chang AY, Ruckdeschel JC, Phan SC, Blum RH.
    Cancer J Sci Am; 2000 Feb 01; 6(1):34-9. PubMed ID: 10696737
    [Abstract] [Full Text] [Related]

  • 11. [The effect of combination chemotherapy with cisplatin, vincristine, doxorubicin and etoposide (Tokushima-CODE: T-CODE) against lung cancer].
    Yanagawa H, Bando H, Takishita Y, Shinohara T, Tanaka H.
    Gan To Kagaku Ryoho; 1992 Aug 01; 19(9):1403-5. PubMed ID: 1323959
    [No Abstract] [Full Text] [Related]

  • 12. [Chemotherapy for small cell lung cancer].
    Fukuoka M, Takada M, Masuda N, Furuse K, Saijo N, Ikegami H, Nishiwaki Y.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec 01; 31 Suppl():225-31. PubMed ID: 7516450
    [Abstract] [Full Text] [Related]

  • 13. [Studies of the possibility of long-term survival of patients with small cell lung cancer].
    Pawlicki M, Krochmal M, Krzemieniecki K.
    Pneumonol Alergol Pol; 1992 Dec 01; 60(5-6):26-9. PubMed ID: 1337851
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.
    Lindgren D, Cadman E, Erichson R, Grann V, Sachs K.
    Cancer Treat Rep; 1984 Sep 01; 68(9):1159-61. PubMed ID: 6090015
    [Abstract] [Full Text] [Related]

  • 16. Multicenter randomized open-label phase III study comparing efficacy, safety, and tolerability of conventional carboplatin plus etoposide versus dose-intensified carboplatin plus etoposide plus lenograstim in small-cell lung cancer in "extensive disease" stage.
    Heigener DF, Manegold C, Jäger E, Saal JG, Zuna I, Gatzemeier U.
    Am J Clin Oncol; 2009 Feb 01; 32(1):61-4. PubMed ID: 19194127
    [Abstract] [Full Text] [Related]

  • 17. [Chemotherapy of small cell lung cancer].
    Komiya T, Takada M.
    Gan To Kagaku Ryoho; 1996 Aug 01; 23(9):1116-23. PubMed ID: 8751797
    [Abstract] [Full Text] [Related]

  • 18. Treatment of small cell lung cancer: experience at Maharaj Nakhon Chiang Mai Hospital.
    Thongprasert S, Jiemsripong K, Phothirat C, Atikachai B.
    J Med Assoc Thai; 1991 May 01; 74(5):253-6. PubMed ID: 1664446
    [No Abstract] [Full Text] [Related]

  • 19. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M, Erturk D.
    Saudi Med J; 2003 Jun 01; 24(6):628-31. PubMed ID: 12847592
    [Abstract] [Full Text] [Related]

  • 20. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
    Timmer-Bonte JN, de Boo TM, Smit HJ, Biesma B, Wilschut FA, Cheragwandi SA, Termeer A, Hensing CA, Akkermans J, Adang EM, Bootsma GP, Tjan-Heijnen VC.
    J Clin Oncol; 2005 Nov 01; 23(31):7974-84. PubMed ID: 16258098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.